Histone acetyltransferase activators and uses thereof
The invention provides for a method for screening compounds that bind to and modulate a histone acetyltransferase protein. The invention further provides methods for treating neurodegenerative disorders, conditions associated with accumulated amyloid-beta peptide deposits, Tau protein levels, and/or accumulations of alpha-synuclein as well as cancer by administering a HAT-activating compound to a subject.
1. A compound having the following structure
or a pharmaceutically acceptable salt or hydrate thereof.
2. The compound of claim 1 , wherein the compound is a pharmaceutically acceptable salt.
3. The compound of claim 2 , wherein the pharmaceutically acceptable salt is an acid addition salt.
4. The compound of claim 3 , wherein the compound is a hydrochloride salt.